Skip to main content
Caplight Logo









Aptila Biotech

Aptila Biotech

Private
BerlinHealthcare & Life Scienceshttps://aptila.bio/

Last Round

Seed

Mar 25, 2025

Company Overview

Aptila Biotech GmbH is a biotechnology company that develops AI-powered software for processing mass spectrometry proteomics data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Healthcare Analytics, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

proteomics softwaremass spectrometry softwareDIA-NNproteomics data analysisdata-independent acquisitionDIAbioinformatics softwareAI for proteomicscomputational proteomicsprotein quantificationprotein identificationneural network softwarehigh-throughput proteomicsdrug discovery softwarefreemium SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aptila Biotech Comparables

Compare Aptila Biotech with similar companies based on industry and business-model similarity.

Aptila Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MSAID GmbH
84%
Bioinformatics Solutions Inc.
77%
Matrix Science
76%

Aptila Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 25, 2025

Aptila Biotech Investors

Notable investors and investment history

Aptila Biotech investors
InvestorRounds
AscenionSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 608% MoM.

  • Apr 5, 2026

    Monthly visitors grew 142% MoM, reaching 1.5K.

Aptila Biotech Filings

Explore SEC and related filing metadata, where available.

Aptila Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aptila Biotech's valuation, stock price, and market status.

Is Aptila Biotech a public or private company?

Aptila Biotech is a private company.

What is the current stock price of Aptila Biotech?

Aptila Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Aptila Biotech worth (valuation)?

Valuation information for Aptila Biotech is not publicly available.

Can I buy Aptila Biotech stock?

Aptila Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aptila Biotech's last funding round?

Funding round information for Aptila Biotech is not publicly available.

Who are the main investors in Aptila Biotech?

Investor information for Aptila Biotech is not publicly disclosed.

Will Aptila Biotech IPO soon?

No public IPO plans have been announced for Aptila Biotech.

How can I track Aptila Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aptila Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range2
Year FoundedN/A
Last FundingMar 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?